Deputy Director VITRAKVI Marketing
Employment Type: Full-Time
Your tasks and responsibilities As of Nov. 2018, VITRAKVI became the first approved TRK Inhibitor in the US and the first product ever to gain its initial FDA approval based on tumor genomic profile rather than the site of the tumor. VITRAKVI is approved for use in any solid tumor that has an NTRK gene fusion - this fusion is rare (
Loading some great jobs for you...